Stanford University
Showing 371-380 of 1,976 Results
-
Kate Hardy
Clinical Professor, Psychiatry and Behavioral Sciences
BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 20 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy is the co-director for the INSPIRE clinic at the Department of Psychiatry and Behavioral Health, Stanford University and has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population and is the co-editor of the book Intervening Early: A team approach.
Dr. Hardy is also the director of INSPIRE training and within this role has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. INSPIRE training offers training in evidence based interventions for psychosis to providers across diverse settings. In 2024 Dr. Hardy became president elect for IEPA: Intervening Early in Mental Health. -
Aubrey Hargrave
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioMy research interests are centered on ocular immunology and neuroinflammation. My long-standing interest in eye research stems from personal experience with eye disease, which has led me to explore vision research and underlies my passion for disease-centric research in order to improve quality of life for patients.
I am fascinated by the immune response and inflammation, in part because of its broad applicability to many human diseases. To this end, I am interested in developing an understanding of the interplay between the immune and nervous systems in the ocular microenvironment and my past research has allowed me to explore this interplay within diverse areas of the eye. As an undergraduate, I conducted research with Dr. Rima Mcleod to study patients with toxoplasmosis, a disease affecting both ocular and neural tissue. We created a patient database and investigated whether genotype influences the inflammatory response to the t.gondii parasite. As a predoctoral student with Dr. Alan Burns, my research focused on ocular inflammation in two cases; first, in acute inflammation following a corneal abrasion and second, in the context of systemic inflammation caused by early metabolic syndrome. I analyzed the immune response in both cases and developed methods to determine the effect on corneal nerves.
During my postdoctoral training with Dr. Alfredo Dubra, I am continuing to build on my previous training in vision science, inflammation, and neurodegeneration by using adaptive optics imaging, in conjunction with standard clinical measurements, to explore potential biomarkers in diseases such as multiple sclerosis, glaucoma, and retinal degeneration. With high-resolution in vivo adaptive optics imaging we are able to monitor changes in retinal tissues at the cellular level over time, as well as to observe minute changes in the retina with treatment during clinical trials.
